🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Starting Now: Translational Biology Moderated by: Robert Haddad #DAVAHawaiiLung

Thank you, DAVA Oncology , for having this amazing Head & Neck Crew at the 3rd Hawaii Summit on Thoracic Oncology (now with a head and neck section)!

U.S. News & World Report's Best Hospitals list ranked University of Chicago Medical Center's Cancer and ENT programs highest in Illinois. Additionally, UCMC is one of only 25 hospitals nationwide to have at least 10 ranked specialties. uchicagomedicine.org/forefront/news…

Experts at UChicago Medicine successfully treated and cured stage IV oral cancer patient Pat Sirvinskas with a unique approach that spared her tongue. Hear her story in her own words. Nishant Agrawal Ari Rosenberg Aditya Juloori UChicagoOHNS ow.ly/ksE550SPooT

🔍 Check out the new episode on Head and Neck Cancer with Ari Rosenberg from the University of Chicago Ari Rosenberg 🎧 Unveiling the Invisible Enemy: Head and Neck Cancer Insights 🎤 Available via: medinsightsunleashed.com/unveiling-the-… #hnscc #headandneckcancer

🔍 Check out the new episode on Head and Neck Cancer with Ari Rosenberg from the University of Chicago Ari Rosenberg 🎧 Unveiling the Invisible Enemy: Head and Neck Cancer Insights 🎤 Available via: medinsightsunleashed.com/unveiling-the-… #hnscc #headandneckcancer

Great to see advances. Time to have large phase III trials incorporating immunotherapy before and/or after definitive chemoradiation. We tried concurrent, didn’t work, should not give up on the finding the right place for IO for those undergoing organ preservation.

Wonderful discussing novel treatment approaches towards improving outcomes in head and neck cancer on the podcast! University of Chicago Hematology/Oncology UChicagoCancerCenter

Enfortumab Vedotin in heavily pretreated recurrent/metastatic head and neck cancer. Jessica Geiger Paul Swiecicki Emrullah Yilmaz MD, PhD UChicagoCancerCenter University of Chicago Hematology/Oncology ascopubs.org/doi/10.1200/JC…

Viral-epitope specific antitumor immune therapeutic strategies warrant further development. annalsofoncology.org/article/S0923-…

🧐Our DEPEND trial is out! Neoadjuvant nivo/chemo followed by response-stratified CRT in HPV-negative stage IVa/b HNSCC. UChicagoCancerCenter University of Chicago Hematology/Oncology Aditya Juloori Pearson Lab Nishant Agrawal Evgeny Izumchenko Everett Vokes jamanetwork.com/journals/jamao…

‼️Our faculty in the media‼️ Dr. Ari Rosenberg is featured in Inside Precision Medicine talking about his most recent study on immunotherapy + chemotherapy for HPV-negative head & neck cancers. Read the full piece at insideprecisionmedicine.com/topics/oncolog…

🌟 FUTURE LEADERS: Dr. Ari Rosenberg on Personalized Care & Innovation Dr. Rosenberg shares his journey in oncology, life-changing decisions & the future of immunotherapy & targeted therapies in head and neck cancer treatment. Watch now: touchoncology.com/insight/future… Ari Rosenberg

April is Head and Neck Cancer Awareness Month! Help spread awareness and share/repost some "Facts to Know" about a common Head and Neck Cancer - HPV-related Oropharyngeal Cancer #HPV ~ AHNS Patient & Public Education Service #AHNS #headandneckcancer #headandneckcancerawareness

Neoadjuvant Nivolumab/Chemo Shows Promise in HPV-Negative HNSCC targetedonc.com/view/neoadjuva… via @targetedonc

‘Super excited about #ASCO25 for several reasons. I feel immensely grateful to have been selected for the 2025 ASCO Annual Meeting Merit Award. Special thanks to my phenomenal mentor Ari Rosenberg.

Honored to be included with such an incredible group of cancer researchers - much work remains to improve outcomes for our cancer patients.🧐🔬🧬💪

Read our review on ADCs in head and neck cancer. There are some promising targets currently under investigation. Ari Rosenberg touchONCOLOGY

From ambient dictation tools to FDA-approved diagnostics, #AI is transforming oncology! At #ASCO25, Alexander Pearson, MD, PhD presents how AI is reshaping clinical cancer care—from research to bedside. UChicago Medicine University of Chicago Hematology/Oncology Pearson Lab

At #ASCO25, Faith Abodunrin, MD (Faith Abodunrin MD) presented a poster showing promising findings on functional and survival outcomes in HPV-positive oropharyngeal cancer with response-adaptive radiation de-escalation strategy. UChicagoOHNS Ari Rosenberg University of Chicago Hematology/Oncology